A Clinical Trial to Compare Lasotronix Alone or in Combination With CPP-ACP to Treat DH

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age25-65
SponsorDow University of Health Sciences

About this trial

Dentin hypersensitivity (DH) is defined as sharp pain of a shorter duration arise from exposed dentin in response to several chemicals and thermal or tactile stimuli that cannot be ascribed to other dental defects". DH has a prevalence rate ranging from 1.3% to 92.1%, commonly affecting old ages. The use of laser has opened new dimensions in the treatment of DH. To the author's knowledge, not much research work has been conducted using LASOTRONIX as a treatment modality with CPP-ACP. Therefore, this research aims to determine the effectiveness of Casein phospho peptide paste (CPP-ACP) used alone or combined with a diode laser (LASOTRONIX).

Eligibility criteria

Qualifiers

Patients of either gender, with ages between 25-65 years

should have at least more than one hypersensitive and vital tooth without any carious lesion or defective restoration

Disqualifiers

History of desensitizing therapy on the affected tooth/teeth in last six months (use of desensitizing toothpaste)

use of antibiotics /analgesic/anti-inflammatory drugs

history of smoking

pregnancy

Trial design

Treatments tested in this trial

  • Active comparator
  • Experimental group
  • Combination of laser and paste
  • Control group

Treatment groups

120 Participants
are divided into 4 treatment groups